FDA — authorised 11 June 2020
- Application: BLA761142
- Marketing authorisation holder: VIELA BIO
- Local brand name: UPLIZNA
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 UPLIZNA in United States
FDA authorised UPLIZNA on 11 June 2020
Marketing authorisation
UPLIZNA in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is UPLIZNA approved in United States?
Yes. FDA authorised it on 11 June 2020.
Who is the marketing authorisation holder for UPLIZNA in United States?
VIELA BIO holds the US marketing authorisation.